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The random rearrangement of TCR coding 
sequences creates an enormously diverse reper-
toire that includes many autoreactive specificities. 
Several mechanisms are involved in eliminating 
and silencing these T cells to safeguard against 
autoimmunity. The majority of autoreactive 
CD8+ T cells are removed in the thymus where 
T cells bearing receptors which react strongly 
to self-peptides presented by MHC undergo apo-
ptotic cell death (negative selection; Kisielow 
et al., 1988; Palmer, 2003; Starr et al., 2003; 
Stritesky et al., 2012). A key mechanism, which 
enables the thymus to eliminate not only T cells 
specific for ubiquitously expressed antigen but 
also T cells responding to antigens that are other-
wise only found in specialized peripheral tissues 
(tissue-restricted antigen [TRA]; Klein et al., 
2009), is the ability of medullary thymic epithe-
lial cells (mTecs) to ectopically express TRA in 
the thymus. The critical importance of providing 
these antigens for negative selection is under-
scored by the fact that mice and humans develop 
severe autoimmunity when they lack the tran-
scription factor AIRE, which is required for the 
ectopic expression of TRA by mTec (Anderson 
et al., 2002; Liston et al., 2004; Mathis and Benoist, 
2009). In addition, autoreactive T cells can be 
eliminated by lymph node–resident immature 
dendritic cells that present tissue-derived anti-
gen (Kurts et al., 1997; Morgan et al., 1999; 
Belz et al., 2002) as well as by lymph node stro-
mal cells. The latter are also able to ectopically 
express TRA (Lee et al., 2007; Metzger and 
Anderson, 2011). Together, these thymic and 
peripheral mechanisms ensure that T cells are 
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Central and peripheral tolerance prevent autoimmunity by deleting the most aggressive 
CD8+ T cells but they spare cells that react weakly to tissue-restricted antigen (TRA).  
To reveal the functional characteristics of these spared cells, we generated a transgenic 
mouse expressing the TCR of a TRA-specific T cell that had escaped negative selection. 
Interestingly, the isolated TCR matches the affinity/avidity threshold for negatively selecting  
T cells, and when developing transgenic cells are exposed to their TRA in the thymus, only  
a fraction of them are eliminated but significant numbers enter the periphery. In contrast to 
high avidity cells, low avidity T cells persist in the antigen-positive periphery with no signs 
of anergy, unresponsiveness, or prior activation. Upon activation during an infection they 
cause autoimmunity and form memory cells. Unexpectedly, peptide ligands that are weaker in 
stimulating the transgenic T cells than the thymic threshold ligand also induce profound 
activation in the periphery. Thus, the peripheral T cell activation threshold during an infec-
tion is below that of negative selection for TRA. These results demonstrate the existence of 
a level of self-reactivity to TRA to which the thymus confers no protection and illustrate 
that organ damage can occur without genetic predisposition to autoimmunity.
© 2012 Enouz et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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of imprinting of any tolerance mechanisms on cells that escape 
negative selection reveal a significant deficit in tolerance en-
forcement and the existence of a range of self-reactivity against 
TRA to which thymic and peripheral tolerance confer no pro-
tection. Together, our observations imply that autoimmunity 
can occur in the absence of any defects in negative selection 
and in the presence of functional regulatory T cells.
RESULTS
Detection of low avidity autoimmune T cells  
in the periphery of normal mice
Low avidity autoreactive T cells have been detected in several 
experimental setups and they can best be studied in transgenic 
systems expressing a model antigen as a neo self-antigen. Such 
a setup allowed us to directly compare the quality of antigen-
specific T cells that can be found in the presence or the absence 
of the neo self-antigen. Rat insulin promoter (Rip)–mOva 
mice express a membrane-bound form of Ova in mTec in the 
thymus, the  cells in the islets of Langerhans in the pancreas, 
the proximal tubular epithelial cells in the kidneys, and, in the 
case of male mice, in the testis (Kurts et al., 1997). OT-1 TCR 
transgenic T cells, which respond with high avidity to an Ova 
epitope, are negatively selected in the thymus of Rip-mOva 
mice and are eliminated in the periphery when injected 
into Rip-mOva mice (Kurts et al., 1997; Gallegos and Bevan, 
2004). We previously used Rip-mOva mice with an elevated 
precursor frequency of Kb/Ova-specific T cells (by crossing 
them with a mouse expressing a transgenic Kb/Ova-specific 
TCR- chain) to show that high avidity Ova-reactive T cells 
were efficiently deleted but low avidity T cells could be found 
in the periphery of these mice (Zehn and Bevan, 2006). To ask 
if the same would happen in Rip-mOva mice with a nontrans-
genic endogenous T cell repertoire, we infected Rip-mOva 
mice and transgene negative littermate controls with a strain of 
Listeria monocytogenes (Lm) that expresses Ova (Lm-Ova). After 
the infection, only very low numbers of Ova/Kb reactive CD8+ 
T cells were observed in Rip-mOva mice (Fig. 1, A and B) and 
none of the infected mice developed signs of autoimmunity 
(not depicted). However, when Lm-Ova–primed Rip-mOva 
mice were challenged with a second Ova-expressing pathogen, 
vesicular stomatitis virus (VSV)–Ova, then the Ova-reactive 
T cells expanded to much higher numbers (Fig. 1, A and B). 
This higher frequency allowed us to assess the functional avidity 
of these Ova-specific T cells and we noted that 50–100-fold 
higher peptide concentration was needed to trigger a half-
maximum (EC50) IFN- response by Kb/Ova-specific T cells 
in Rip-mOva mice compared with control C57BL/6 mice 
(Fig. 1, C and D). These data show that T cells responding 
with high functional avidity to the Kb/Ova antigen are elimi-
nated from the T cell repertoire in Rip-mOva mice, whereas 
lower avidity T cells remain.
Autoimmune responses targeting pancreatic  cells in 
Rip-mOva mice are usually induced upon transferring high 
avidity Ova-specific CD8+ T cells into the mice. To our 
knowledge, no disease induction has been reported in Rip-mOva 
mice relying entirely on endogenous T cells with physiological 
negatively selected against all self-antigens. However, the fre-
quent occurrence of T cell–mediated autoimmune diseases 
such as type 1 diabetes and multiple sclerosis indicate that the 
establishment or maintenance of tolerance can fail. How this 
occurs and if autoimmunity inevitably requires defects in toler-
ance enforcing mechanisms or if even healthy individuals with 
a normally selected T cell repertoire and without any genetic 
predisposition can develop autoimmunity remains unknown.
The critical contribution of regulatory T cells in maintain-
ing tolerance underlines the fact that T cells with autoreactive 
potential are part of the normal T cell repertoire in healthy 
individuals (Josefowicz et al., 2012). Moreover, there is con-
clusive evidence that the mechanisms which select the T cell 
repertoire remove only the most aggressive TRA-specific 
T cell clones but spare T cells with less avidity for TRA. These 
lower avidity T cells persist in the periphery but they have 
the potential to cause autoimmunity even in the presence of 
regulatory T cells (von Herrath et al., 1994; Zehn and Bevan, 
2006). Despite many observations which imply that low avi-
dity T cells are key mediators of autoimmunity (Bulek et al., 
2012), we lacked strategies and tools to study these T cells 
in defined experimental systems. Hence, most prior investiga-
tions were limited to observing autoimmune responses in-
duced by high avidity T cells and thus dealt with T cells that 
are normally effectively eliminated by central and peripheral 
tolerance. In contrast, the biological properties of T cells with 
physiologically relevant levels of self-reactivity and which are 
not eliminated in the thymus or the periphery remained un-
known. Most importantly, there was a lack of knowledge 
regarding the phenotypic and functional characteristics of 
these T cells before their activation and expansion in ongoing 
autoimmune responses and we did not know if any tolerance 
mechanisms normally prevent these cells from causing auto-
immunity in healthy individuals. Finally, it was not known 
what stimuli are needed to convert cells that escaped negative 
selection into self-reactive effector T cells in the periphery and 
to what degree they can respond to self-antigen.
To address these questions in a well defined experimental 
system, we developed a novel transgenic mouse expressing a 
TCR that barely escapes negative selection by a TRA, i.e., one 
that is at the threshold of thymic negative selection versus sur-
vival. We show that in this model system, escaped low avidity 
autoreactive T cells are quiescent under steady-state conditions 
in the presence of their target TRA, but during an infection 
they are able to respond to antigen stimulation as well as for-
eign antigen-reactive T cells. This includes their differentiation 
to fully functional effector T cells and the formation of mem-
ory upon stimulation by cross-reactive foreign ligands. This 
occurs even in response to altered peptide ligands (APLs) that 
provide much lower levels of stimulation than the native ligand 
that failed to negatively select a large fraction of the cells. Im-
portantly, in this model system even during a bystander in-
fection the low avidity autoreactive T cells have the ability to 
respond to endogenous levels of self-antigen. Thus, autoreac-
tive T cells can respond during an infection to a self-ligand that 
failed to delete T cells in thymus. This difference and the lack 
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levels of self-reactivity and in the presence of an intact regula-
tory T cell compartment. Notably, we found T cell infiltrates 
in the pancreatic islets of 60–80% of doubly infected Rip-mOva 
mice, whereas such infiltrates were absent in littermate con-
trols (Fig. 2). In addition, 30% of the Rip-mOva mice primed 
with Lm-Ova and boosted with VSV-Ova had blood glucose 
levels exceeding 200 mg/dl, an elevated level which we did 
not observe in the parallel littermate control group (Fig. 1 E). 
Reversing the order of infections or challenge of low-dose 
Lm-Ova–primed mice with a high dose of Lm-Ova did not 
lead to higher disease incidence (unpublished data). From these 
observations, we conclude that low avidity self-reactive T cells 
can be found in all Rip-mOva mice and that when these cells 
are expanded to high numbers, they are able to cause tissue 
destruction and autoimmune diabetes.
OT-3: a novel transgenic mouse expressing  
a low avidity Kb/Ova-specific TCR
Although the aforementioned data, as well as other observa-
tions (von Herrath et al., 1994; Zehn and Bevan, 2006; Bulek 
et al., 2012), demonstrate the existence of low avidity auto-
reactive T cells in the periphery, these T cells have only been 
characterized after they had been expanded by immunization. 
However, their phenotypic and functional characteristics 
before expansion, and how low avidity autoreactive T cells 
respond to antigen stimulation in healthy individuals, remained 
unknown. To investigate this, we isolated a Kb/Ova-specific 
CD8+ T cell receptor from a diabetic Rip-mOva mouse, as 
Figure 1. Low avidity Kb/Ova-specific T cells in the periphery  
of Rip-mOva mice. Rip-mOva or transgene negative littermate control 
C57BL/6 mice were infected with Lm-Ova. A fraction of the mice were 
rechallenged 4 wk later with VSV-Ova. 6 d after the last infection, spleno-
cytes were isolated and either left untreated or were briefly in vitro  
restimulated with SIINFEKL peptide. In A, CD8+ gated flow cytometry plots 
of cells intracellularly stained for IFN-, and in B, the frequencies of Ova-
specific T cells are depicted (n = 3–4 mice per group). Dose–response 
curves graphing peptide concentration against the fraction of maximum 
IFN- response in splenic CD8+ T cells are shown in C (n = 4 and 5 per 
group, error bars show SD). The data shown in A–C are representative of 
three independently performed experiments. (D) Calculated mean half-
maximum effective concentrations (EC50) obtained in three independent 
experiments (each including three to five mice per group) are presented. 
(E) Maximum blood glucose levels between days 7 and 13 after the sec-
ondary infection. The data are pooled from eight independent experi-
ments (total number of mice: 56 Rip-mOva and 26 littermate control, 
transgene-negative C57BL/6 mice). The horizontal bars in B and D repre-
sent the mean value of the individual data points. Figure 2. T cells infiltrate the islets of Rip-mOva mice after  
sequential Lm-Ova and VSV-Ova infection. C57BL/6 or Rip-mOva mice 
were infected with Lm-Ova and, 4 wk later, with VSV-Ova. Representative 
images of anti-CD8–stained pancreas sections obtained at day 8 after the 
secondary infection are presented. Bars, 50 µm. Results from one of two 
representative experiments are shown with n = 5 mice per group.
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SIINFEKL (N4) ligand (Alam et al., 1996; Daniels et al., 
2006). Interestingly, OT-1 T cells respond to the SIITFEKL 
(T4) APL with a similar functional avidity as OT-3 T cells 
respond to Kb/Ova (Fig. 3 C), and the ligands induce compa-
rable numbers of OT-1 and OT-3 effector and memory T cells 
after Lm-T4Ova or Lm-Ova infection, respectively (Fig. 3 D). 
Note that T4 is the weakest ligand described that still induces 
negative selection of OT-1 T cells in fetal thymic organ cultures 
(Daniels et al., 2006). Because of this, the T4 ligand is 
thought to mark the avidity/affinity threshold between posi-
tive and negative selection of OT-1 cells. The similar func-
tional avidity of OT-3 T cells to Kb/Ova and OT-1 T cells 
to Kb/T4 suggests that Kb/Ova is the threshold ligand for 
OT-3 T cells.
This conclusion was further supported by grafting le-
thally irradiated Rip-mOva or C57BL/6 recipient mice 
with a mixture of C57BL/6 and OT-3 bone marrow cells. 
After reconstitution, we observed that Rip-mOva recipi-
ent mice contained, compared with the numbers in control 
C57BL/6 recipients, only half the number of OT-3 T cells in 
the peripheral blood, in pancreatic lymph nodes, and among 
CD8+ single-positive CD24low thymocytes (Fig. 4). This 
difference was also seen at 20 wk after bone marrow re-
constitution (Fig. 4 A). The stability in the ratio of peripheral 
OT-3 T cells between C57BL/6 and Rip-mOva mice in-
dicates that OT-3 T cells were largely eliminated in the thy-
mus but not in the periphery of Rip-mOva mice. Overall, 
these results indicate that 50% of the OT-3 T cells bypass 
negative selection in Rip-mOva in a stochastic manner and 
that Kb/Ova appears to be the threshold ligand for OT-3 
T cells in these mice.
described in Materials and methods, and then created a 
TCR transgenic mouse (designated as OT-3). To exclude 
any contribution by secondary, endogenously rearranged 
TCR- chains, we crossed the OT-3 mice onto a Rag2/ or 
TCR-/ background and only such OT-3 T cells were 
used in the entire study. We observed that TCR transgenic 
OT-3 T cells required 50× higher Ova peptide concentra-
tion for half-maximum IFN- production than OT-1 T cells 
(Fig. 3, A and C). Comparing the OT-3 T cells with the 
cells seen in doubly infected Rip-mOva mice, we noticed 
that the OT-3 T cells were slightly more sensitive to Kb/Ova 
and showed a steeper titration slope than the endogenous 
population in Rip-mOva mice (Fig. 3 A). This result is not 
unexpected as OT-3 T cells are a monoclonal population in 
which all cells have the same functional avidity for Kb/Ova. 
In contrast, the slower increase in the titration curve of en-
dogenous T cells indicates that this is a mixed population of 
cells, some of which have similar and others lower functional 
avidity for Kb/Ova compared with OT-3 T cells. To charac-
terize the OT-3 T cells further, we examined their ability to 
induce diabetes in Rip-mOva mice and found that 30,000 
transferred OT-3 T cells caused severe diabetes within 6 d after 
an Lm-Ova infection, and as few as 3,000 OT-3 T cells in-
creased blood glucose levels (Fig. 3 B). We observed that the 
avidity of the OT-3 T cells was too low to reliably stain them 
with conventional tetramers (unpublished data).
OT-3 T cells match the TCR stimulation threshold  
for negative selection against the Ova antigen
Several APLs have been identified that provide lower levels 
of stimulation to OT-1 T cells than the native Ova-derived 
Figure 3. OT-3 T cells respond with similar functional 
avidity to Kb/Ova as OT-1 T cells respond to SIITFEKL. 
(A) 800 OT-3 T cells were transferred into Rip-mOva mice 
which were infected with Lm-Ova and, 4 wk later, with  
VSV-Ova. 104 OT-1 T cell–engrafted control C57BL/6 mice 
were infected with VSV-Ova. Splenocytes from both groups 
were restimulated with SIINFEKL peptide and stained for 
IFN-. The corresponding peptide dose–response curves for 
OT-3, OT-1, and endogenous T cells in Rip-mOva mice are 
shown (n = 3 or 4, error bars show SD). The data are repre-
sentative of two independent experiments. (B) Rip-mOva 
mice, supplemented with titrated numbers of OT-3 T cells, 
were infected with Lm-Ova, and blood glucose levels were 
determined 6, 8, and 10 d after infection. Data are represen-
tative of three independent experiments (n = 4–6 mice). 
Because of the diabetes, the mice engrafted with the highest 
number of OT-3 T cells had to be sacrificed after day 8 
(marked with a cross). (C) 2 × 104 naive OT-1 and 105 OT-3  
T cells were transferred into CD45.1 congenic mice which 
were infected with Lm-Ova. Splenocytes were stimulated 
with titrated doses of SIINFEKL (N4) or SIITFEKL (T4) peptide 
(OT-1 only) at 7 d after infection and intracellularly stained 
for IFN-. The resulting dose–response curves are shown (n = 4, data are representative of three experiments, SD error bars are shown). (D) 105 OT-1 and 
OT-3 T cells were transferred into CD45.1 congenic hosts. OT-1 mice were infected with Lm-T4Ova and OT-3 mice with Lm-Ova. OT-1 and OT-3 T cell fre-
quencies at days 6 and 28 after infection and 6 d after a secondary VSV-Ova infection are presented. The horizontal bars represent the mean value of the 
individual data points. The data are representative of two independent experiments with n = 3–4 mice per group.
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Moreover, lymphocytic choriomeningitis virus (LCMV) in-
fection matures these DCs and it has been shown that 
LCMV-infected Rip-mOva mice facilitate OT-1 T cell expan-
sion, effector differentiation, and autoimmunity triggered by 
endogenous Kb/Ova (Zehn and Bevan, 2006). We used the 
same system to test if OT-3 T cells respond to endogenous 
levels of Kb/Ova. Interestingly, we observed that even low 
avidity OT-3 T cells proliferated and down-regulated CD62L 
in LCMV-infected Rip-mOva mice (Fig. 5). This indicates 
that recognition of endogenous Kb/Ova is able to trigger the 
activation of naive OT-3 T cells after LCMV infection. The 
activation of OT-3 T cells by peripheral Kb/Ova contrasts 
with the inefficient negative selection against Kb/Ova. The 
result indicates that autoreactive T cells which escape negative 
selection can nevertheless respond to peripheral self-antigen 
during a systemic viral infection.
Even weaker ligands than Kb/Ova trigger the activation  
of OT-3 T cells during an infection
To directly address the sensitivity of OT-3 T cells to antigen 
stimulation in the periphery, we screened a large collection of 
SIINFEKL-derived APL to identify ligands that are weaker in 
stimulating OT-3 T cells than Kb/Ova. We identified SIFNFEKL 
(F3) and SIVNFEKL (V3) to be such ligands (Fig. 6 A). To 
our surprise, we observed that Lm expressing these ligands in-
duced robust OT-3 T cell expansion (Fig. 6 B). This occurred 
even though they have a 35- or 200-fold lower EC50 value than 
the negative selection threshold ligand SIINFEKL (Fig. 6 A). 
V3- and F3-primed effector T cells exhibited a normal pat-
tern of CD44 and CD62L expression and secreted IFN- 
and TNF. Most of the OT-3 T cells from both groups pro-
duced granzyme B (Fig. 6, C and D). When Lm-V3–primed 
OT-3 T cells were challenged 4 wk later with VSV-Ova, we 
observed much higher numbers of OT-3 T cells (Fig. 6 E, left) 
compared with recipients that received OT-3 T cells but were 
primed with WT Lm (Lm-wt) that do not express Ova (Fig. 6 E, 
right). The few cells seen in the Lm-wt group on day 4 after 
the VSV-Ova infection are OT-3 T cells that persisted through-
out the Lm infection and that mounted a primary response 
after the VSV-Ova infection. This indicates that even a sub-
threshold level of stimulation is sufficient to generate func-
tional memory T cells with the potential to mount a secondary 
effector T cell response. Moreover, Lm-V3–primed OT-3 
T cells lysed antigen-pulsed target cells in vivo (Fig. 6 F). To test 
the ability of these subthreshold ligands to induce functional 
Endogenous antigen level provides sufficient stimulation  
to activate OT-3 cells in a bystander infection
The escape of low avidity self-reactive T cells from negative 
selection would only be a problem for self-tolerance if those 
cells could efficiently be activated in the periphery. The data 
shown in Fig. 3 B already demonstrate that effector OT-3 
T cells bear sufficient functional avidity to destroy pancreatic 
islet cells in Rip-mOva mice after Lm-Ova immunization. 
In addition, we wanted to know if OT-3 T cells could be acti-
vated by endogenous Kb/Ova presentation. It is well docu-
mented that Kb/Ova is presented in Rip-mOva mice by 
immature DC-draining Ova-expressing organs such as the 
pancreas or kidneys (Kurts et al., 1997; Belz et al., 2002). 
Figure 4. Survival of a large fraction of OT-3 T cells in the thymus  
of Rip-mOva mice. (A and B) Lethally irradiated Rip-mOva or C57BL/6 
mice (both coexpress CD45.1 and CD45.2) were injected with a 4:1 mix of 
C57BL/6 (CD45.1) and OT-3 (CD45.2) bone marrow. (A–C) Frequency of 
OT-3 T cells among total CD8+ T cells in these mice was measured at 6.5 wk 
(n = 12 per group) or 20 wk (n = 8 and 6 per group) after reconstitution 
in the peripheral blood (A), at 9 wk in the pancreatic lymph nodes  
(n = 4 and 5 mice per group; B), and at 5 wk among CD8+ CD24 low  
single-positive thymocytes (n = 8 and 6 per group; C). Six independent 
experiments were performed to assess the frequency of OT-3 at 5.5–7 wk 
in the blood and three experiments at the later time point. The measure-
ments in the pancreatic lymph nodes are representative of two independent 
experiments. The horizontal bars in A, B, and C represent the mean value 
of the individual data points.
Figure 5. Endogenous Kb/Ova complexes activate OT-3 
T cells during an infection. CD45.1 Rip-mOva or C57BL/6 
mice were injected with 5 × 105 CellTrace Violet–labeled  
OT-3 T cells and infected with LCMV Armstrong. 4 d after 
infection, splenocytes were analyzed for dye dilution and 
CD62L expression levels. (A) Representative OT-3 gated flow 
cytometry plots. (B) Data for all mice (n = 3 or 4 per group). 
The data are representative of three independent experi-
ments. The horizontal bars represent the mean value of the 
individual data points.
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OT-3 T cells that matured in C57BL/6 mice are phenotypically 
or functionally different from OT-3 T cells that developed 
in Rip-mOva mice. Because Ova is a self-antigen for OT-3 
T cells from Rip-mOva mice, we refer to these as self–OT-3 
T cells in contrast to OT-3 T cells from C57BL/6 mice for 
which Ova is a foreign antigen (foreign–OT-3). Using chime-
ric Rip-mOva or C57BL/6 mice reconstituted with a mixture 
of C57BL/6 and OT-3 bone marrow stem cells, we asked if 
there were any phenotypic differences between self– or for-
eign–OT-3 T cells. CD5, CD44, CD25, and PD-1 did not 
show different levels of expression. The similar expression of 
CD44 indicates that in both hosts the OT-3 T cells are naive 
(Fig. 7 A). Consistent with this, self– and foreign–OT-3 T cells 
responded very similarly during an Lm-Ova infection and 
gave rise to effector T cells with comparable IFN- and TNF 
secretion patterns, granzyme B expression levels, and CD127 
and KLRG1 expression (Fig. 7 B). Consis-
tent with these results, self– and foreign–
OT-3 T cells transferred into Rip-mOva 
Figure 6. pMHC ligands with avidities  
far below the negative selection threshold 
induce functional effector and memory  
T cells. (A) An OT-3 T cell line was briefly stimu-
lated with SIINFEKL (N4) or the APLs SIFNFEKL 
(F3) or SIVNFEKL (V3). Shown are dose–response 
curves graphing the peptide concentration 
against the fraction of IFN-–producing T cells. 
(B–E) 105 CD45.1 congenic OT-3 T cells were 
transferred into C57BL/6 mice which were then 
infected with Lm-Ova, Lm-F3, or Lm-V3. Another 
group of mice was infected with nonrecombi-
nant wild-type Lm (wt). (B) The frequency of OT-3  
T cells on day 7 after infection (n = 4 or 5 mice 
per group). (C) Representative flow cytometry 
plots of total CD8+ T cells (left) or OT-3 T cells 
(right) analyzed on day 5.5 after infection for 
granzyme B, CD44, and CD62L expression.  
(D) The same cells briefly restimulated with  
SIINFEKL peptide and stained for TNF and IFN- 
are shown (n = 3 or 4 mice per group in C and D). 
(E) The frequency of OT-3 T cells in mice infected 
with Lm-V3 or control Lm-wt at 6 and 28 d and  
at 4 d after a secondary VSV-Ova infection are 
displayed (n = 4 or 5 mice per group). (F) Rip-mOva 
mice received nothing or 2 × 104 OT-3 T cells 
and infected with Lm-V3. At 5.5 d after infec-
tion, peptide-pulsed CFSEbright and control CFSElow 
splenocytes were injected and analyzed 24 h 
later for the elimination of the CFSEbright popula-
tion. The numbers indicate the percentage and 
SD of CFSEbright cells in Rip-mOva mice supple-
mented with or without OT-3 T cells (n = 3 per 
group). (G) Blood glucose levels at 6–8 d after  
Lm-F3 infection and 105 OT-3 transfer (n = 8 
mice). The horizontal bars in B and E represent 
the mean value of the individual data points.  
All the experiments shown were performed two 
times and we observed similar outcomes.
effector T cells capable of causing autoimmunity, we infected 
Rip-mOva mice containing OT-3 T cells with Lm-F3. The 
mice became diabetic within 8 d after infection (Fig. 6 G). The 
overall picture that emerges from these observations is that 
although Kb/Ova fails to effectively induce negative selection 
of OT-3 T cells in Rip-mOva mice, ligands that are much less 
potent activate OT-3 in the periphery and induce normal 
T cell differentiation. This leads to the conclusion that there is 
a substantial difference in the threshold for negative selection 
to this TRA and peripheral T cell activation after an infection.
Low avidity T cells that escape negative selection  
are not tolerant and differentiate into functional  
effector and memory T cells
Our data show that negative selection in Rip-mOva mice fails 
to eliminate a large fraction of the OT-3 T cells. We asked if 
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mice exhibited a similar capacity to expand and induce dia-
betes (Fig. 7 C).
Next, we tested if the constitutive presentation of Kb/
Ova in lymph nodes of Rip-mOva mice affects the formation 
of OT-3 memory cells. To address this issue, we had to use a 
special experimental setup to ensure that the expanded effec-
tor OT-3 T cells did not cause diabetes. This was achieved by 
using Rip-mOva mice expressing the variant H-2Kbm1 MHC-I 
molecule which is unable to present the SIINFEKL epitope. 
According to a published strategy, we lethally irradiated 
H-2Kbm1/Rip-mOva mice and reconstituted them with 
C57BL/6 bone marrow. This creates a situation in which all 
nonhematopoietic cells express H-2Kbm1 and fail to present 
SIINFEKL. As a consequence, OT-3 T cells cannot destroy 
the pancreatic islets. In the same animals, however, all hema-
topoietic cells express H-2Kb and DC cross-present tissue-
derived Ova antigen (Kurts et al., 1997). Upon transferring 
OT-3 T cells into C57BL/6 >H-2Kbm1/Rip-mOva chimeric 
mice and infecting the hosts with Lm-Ova, we observed that 
the OT-3 cells formed memory T cells. Moreover, when the 
mice were challenged with VSV-Ova 4 wk later, the memory 
OT-3 T cells mounted a robust secondary response (Fig. 7 D). 
The latter findings are particularly important as they indicate 
that even self-reactive T cells with autoimmune potential can 
form functional memory T cells that can expand to larger 
numbers of autoreactive T cells upon reencountering antigen. 
In conclusion, our data show that cells with an avidity/ 
affinity for self-antigen at or just below the threshold for 
negative selection are not impaired in their ability to re-
spond to self-antigen and do not show any signs of cell in-
trinsic anergy or tolerance.
DISCUSSION
Most autoreactive T cells are exposed to self-antigen either in 
the thymus or the periphery, and high avidity T cells are elim-
inated in both compartments. In contrast, lower avidity T cells 
are often found in ongoing autoimmune diseases (Bulek et al., 
2012) and in anti-tumor responses (McMahan and Slansky, 
2007). Thus, expression of a low avidity TCR, allowing auto-
reactive T cells to bypass elimination, is a major mechanism 
by which autoreactive T cells escape tolerance (von Herrath 
et al., 1994; Nugent et al., 2000; Zehn and Bevan, 2006). 
However, up to this point, we had limited insight into the 
phenotypic and functional characteristics of these low avidity 
self-reactive T cells. Thus, it was unclear how self-antigen 
recognition in the thymus or periphery impacts the function 
of these T cells and whether such exposure imprinted mecha-
nisms that restrict their activation. The failure to negatively 
select low avidity self-reactive T cells stimulated us to study 
how well these T cells respond to self-antigen in the periph-
ery. To address these questions, we needed to establish a well 
defined experimental system in which we could study T cells 
Figure 7. Autoreactive OT-3 T cells  
differentiate into normal effector and 
memory T cells. (A) Lethally irradiated Rip-
mOva or C57BL/6 mice were reconstituted as 
described in Fig. 4. 6 wk later, expression lev-
els of CD5, CD44, CD25, and PD-1 on OT-3  
T cells in C57BL/6 mice (termed foreign-OT-3) 
and in Rip-mOva mice (self–OT-3 T cells) were 
determined (representative data for n = 5 
mice per group are shown). The black line 
represents the level of CD5 expression by 
endogenous T cells. The data are representa-
tive of two experiments. (B) Similar chimeric 
mice were infected at 11 wk after reconstitu-
tion with Lm-Ova and, 7 d later, splenocytes 
were stained with GrzB, anti-CD127, and anti-
KLRG1. They were also restimulated with  
SIINFEKL peptide and then stained intracel-
lularly for IFN- and TNF. Shown are OT-3 
gated flow cytometry plots representative of 
n = 3 mice per group. The dashed lines on  
the left are endogenous CD8+ T cells.  
(C) Rip-mOva mice received 5 × 104 foreign– 
or self–OT-3 T cells (described in A), and blood 
glucose levels and T cell expansion were de-
termined after an Lm-Ova infection (n = 5 
mice per group). Values >200 mg/dl were 
considered diabetic. The experiments shown in B and C were performed two times and showed a similar outcome. (D) H-2Kbm1/Rip-mOva mice were  
lethally irradiated and grafted with C57BL/6 bone marrow. 8 wk after the reconstitution, 5 × 104 OT-3 Rag2/ T cells were injected and the mice were 
infected with Lm-Ova. The frequency of OT-3 T cells was determined 6 and 28 d after the Lm-Ova infection and at day 6 after a VSV-Ova rechallenge. The 
data are pooled from two independently performed experiments with n = 3 mice per group and experiment. The horizontal bars in C and D represent the 
mean value of the individual data points.
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Our observations also raise the question of what is needed 
to activate low avidity T cells that bypass negative selection. 
Our experiments shown in Fig. 1 indicate that it is rather dif-
ficult to expand the endogenous Kb/Ova-specific T cells in 
Rip-mOva mice. We considered the possibility that low avidity 
self-reactive T cells are exposed to antigen either in the thy-
mus or in the periphery and that this exposure might render 
the cells less responsive to subsequent stimulation. We there-
fore asked whether Kb/Ova-exposed OT-3 T cells showed any 
phenotypic or functional differences compared with OT-3 
T cells obtained from control C57BL/6 mice but we found 
no evidence for such differences. Instead, OT-3 T cells from 
either source expanded and caused diabetes to a similar extent. 
This indicates that the impaired expansion of the endogenous 
population in Rip-mOva mice is not related to tolerance 
mechanisms but rather to the fact that the cells receive a very 
low TCR stimulation. In fact, we recently reported that the 
duration of T cell expansion (i.e., the number of cell divisions) 
directly correlates with TCR stimulation strength and that 
weakly stimulated T cells expand much less vigorously than 
strongly stimulated T cells (Zehn et al., 2009). Thus, the criti-
cal factors determining whether or not autoimmunity devel-
ops is not only the ability to activate these T cells but, equally 
importantly, to expand them to numbers high enough that 
they cause noticeable tissue destruction.
Applying the latter consideration to the development 
of autoimmunity, we suggest that pathogens which provide 
cross-reactive ligands that activate the T cells more strongly 
than the self-antigen would effectively trigger autoimmunity. 
This conclusion reinforces the importance of activation of 
autoreactive T cells via molecular mimicry. Molecular mimicry 
proposes that T cells responding to a pathogen may cross- 
react with a self-antigen and thereby cause autoimmunity 
(Oldstone, 2005). We mimicked the mechanisms that would 
occur during molecular mimicry by using pathogens that 
provide an antigen that is identical to a self-antigen. In a real 
molecular mimicry situation, a pathogen could introduce a 
cross-reactive antigen that stimulates autoreactive T cells with 
higher avidity than in our setup. This would lead to more 
vigorous expansion of autoreactive T cells and likely lead to 
higher disease incidence.
The finding that ligands which are weaker than the thy-
mic selection threshold activate T cells in the periphery con-
trasts with earlier observations showing that T cells are more 
sensitive to antigen during negative selection in the thymus 
than they are in the periphery (Pircher et al., 1991; Sant’Angelo 
and Janeway, 2002). The earlier studies investigated selection 
against ubiquitously expressed antigens, whereas we studied 
TRA. This has consequences in so far as negative selection to 
ubiquitously expressed antigen can occur already in the thymus 
cortex (Baldwin et al., 2005). Notably, miR-181a, a microRNA 
which enhances antigen sensitivity, is expressed at higher 
levels by double-positive thymocytes than by cells in the medulla 
or in peripheral T cells (Li et al., 2007). miR-181a–mediated 
higher antigen sensitivity could enable negative selection against 
antigen in the thymus cortex, whereas the same antigen might 
expressing a TCR with physiologically relevant functional 
avidity for a defined self-antigen. We built such a model based 
on Rip-mOva mice. After identifying what types of Kb/
Ova-reactive T cells can be found in Rip-mOva mice, we 
generated the novel OT-3 TCR transgenic line to: determine 
the activation threshold of low avidity autoreactive T cells 
in the periphery; track the phenotype, cell fate, and function 
of these low avidity autoreactive T cells; and assess the effect 
of encountering a ligand at the threshold of negative selection 
in the thymus for T cell function in the periphery.
We observed that during an infection, T cells respond 
to a self-antigen that inefficiently induces negative selection 
when promiscuously expressed by mTec in the thymus. 
Moreover, even variants of the self-antigen that are weaker in 
stimulating the OT-3 T cells than Kb/Ova efficiently activate 
the T cells, induce normal effector and memory T cells, and 
cause diabetes. Why T cells respond differently to the same 
antigen in the thymus and the periphery remains unknown. 
Possibly, the number of peptide–MHC complexes resulting 
from the ectopic expression of antigen in the thymus is lower 
than the number of complexes found in an Lm-Ova infec-
tion or during presentation of endogenous Ova in the pe-
riphery. Thus, a weak ligand that fails to eliminate T cells in 
the thymus might sufficiently activate T cells in the periphery 
as the result of a higher epitope abundance. Along with higher 
ligand density, inflammation, higher levels of co-stimulation, 
and presentation by activated DC may create an environment 
that supports the activation of T cells even though they re-
ceive only very weak TCR stimulation.
The fact that inflammation and high levels of antigen pre-
sentation can activate T cells that survive negative selection 
appears less significant to us than the observation that the 
spared T cells induce autoimmunity and effectively destroy 
peripheral tissue cells. This indicates that there is a discrep-
ancy between the safety margin imprinted by the thymus and 
what is needed to completely protect peripheral tissues from 
autoimmunity. Again, the question is why there is such a 
mismatch. Also in this situation, simply more peptide–MHC 
complexes could be presented on peripheral cells than during 
the ectopic expression and presentation in the thymus. Thus, 
instead of a T cell affinity threshold difference there could be 
an avidity (epitope abundance) mismatch between the thy-
mus and the periphery. Whether or not such differences ap-
ply to all antigens or just a fraction of ectopically expressed 
TRA remains to be determined. An additional and non– 
mutually exclusive explanation for why there is a mismatch 
between thymic tolerance end peripheral T cell activation is 
that effector T cells might be more sensitive to antigen rec-
ognition than thymocytes when they are exposed to TRA in 
the thymic medulla. Consistent with this, it has been reported 
that effector T cells are very sensitive to antigen recognition 
and that sensitivity may increase as cells differentiate into 
effector T cells (Slifka and Whitton, 2001). Overall, we inter-
pret our findings to mean that cells which are at the threshold 
of negative selection pose sufficient reactivity to peripheral 
tissue antigen to cause disease.
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were from Charles River. H-2Kbm1 mice were crossed with Rip-mOva 
mice and subsequently intercrossed to obtain Rip-mOva H-2Kbm1 homo-
zygous mice. The mAb clone 5F1 (provided by L. Sherman, Scripps Research 
Institute, La Jolla, CA) binds H-2Kb but not H-2Kbm1 and was used to screen 
the F2 generation. V5 TCR- chain–only transgenic mice (Dillon et al., 1994) 
were provided by P.J. Fink (University of Washington, Seattle, WA). OT-3 
TCR transgenic mice responding with low avidity to Kb/Ova257-264 (described 
in the next section) were crossed to Rag2/ mice or TCR-/ mice (The 
Jackson Laboratory). Mice were bred and maintained in SPF facilities and 
infected mice in conventional animal facilities. Experiments were performed 
in at least 6-wk-old mice in compliance with the University of Lausanne In-
stitutional regulations and were approved by the veterinarian authorities of 
the Swiss Canton Vaud. Isolation of low avidity Kb/Ova-reactive T cells from 
V5xRip-mOva double transgenic mice and pronuclear injections were 
performed at the University of Washington (UW) in compliance with the 
UW Institutional Animal Care and Use Committee regulations.
Generation of the OT-3 TCR transgenic mice. For practical reasons, 
we decided to isolate a low avidity TCR that escapes negative selection from 
the previously described V5xRip-mOva mice (Zehn and Bevan, 2006). 
These mice express a fixed TCR- chain (Dillon et al., 1994) that is iden-
tical to the  chain found in OT-1 mice, but V5xRip-mOva mice have en-
dogenously rearranged TCR- chains. The advantage of using the V5xRip- 
mOva was that, given the fixed TCR- chain, we only needed to isolate an 
appropriate TCR- chain to identify a low avidity Kb/Ova-reactive TCR-/ 
combination. 6–8-wk-old V5xRip-mOva mice (Zehn and Bevan, 2006) 
were infected with Lm-Ova. 7 d later, CD8+ splenocytes were isolated and 
co-cultured with irradiated C57BL/6 splenocytes and titrated concentrations 
of SIINFEKL peptide. The cultures with the lowest peptide concentration 
that still induced T cell proliferation were restimulated after 7 d. After an-
other week, RNA extracted from the cultured cells was reverse transcribed 
using a primer (5-GATGGAGCTTGGGAGTCA-3) complementary to 
the 3 untranslated region of the TCR- chain. A 5 RACE cDNA-based 
strategy (Invitrogen) was used to clone the TCR- chains into a retroviral 
vector (MigR1; Pear et al., 1998). We sequenced 32 clones and analyzed 
them with algorithms provided by the International Immunogenetics Infor-
mation System (www.imgt.org). By doing that, we identified four unique 
and in-frame rearranged TCR sequences. To test whether or not these 
TCR- chains respond to Kb/Ova257-264, we retrovirally transduced them 
into activated CD8+ T cells obtained from V5 transgenic mice. Without 
any manipulation, 1–5% of polyclonal CD8+ T cells in V5 mice respond 
to Kb/Ova257-264 (Zehn and Bevan, 2006). In contrast, three of the four 
isolated TCR- chains strongly elevated the frequency and this con-
firmed their reactivity to Kb/Ova257-264. One TCR- sequence (clone 7) was 
selected to generate the transgenic mouse. According to the sequence 
IMGT/V-QUEST analysis, clone 7 expresses TRAV19 paired with TRAJ26. 
Clone 7 and the IRES GFP sequences from MigR1 were introduced into 
the hDC2 construct using the described restriction sites (Zhumabekov et al., 
1995). Clone7 hCD2 and the vector originally used to generate the V5 
TCR-–only transgenic mice (provided by F. Carbone, University of 
Melbourne, Melbourne, Australia) were digested as previously described 
(Kelly et al., 1993) and co-injected into the pronucleus of fertilized C57BL/6 
zygotes. One of the resulting founder lines was selected and crossed with 
Rag2/ and TCR-/ C57BL/6 mice. All the experiments shown in our 
paper were performed with either OT-3xRag2/ or OT-3xTCR-/ 
mice and gave similar results.
Generation of bone marrow chimera mice. Recipient mice were lethally 
irradiated with 900 rad and, 1 d later, engrafted with bone marrow cells iso-
lated from femur and tibia. Before injecting, the bone marrow was stained 
with biotinylated anti-CD3 antibody (eBioscience), and anti-biotin micro-
beads and T cells were depleted by separation on LS columns (all Miltenyi 
Biotec). The host mice received 300 µg anti-Thy1.2 monoclonal antibody 
2–5 d after bone marrow transfer (Bio-XCell) to deplete residual T cells. Mice 
were treated with antibiotics (Bactrim; Roche) until 3 wk after irradiation.
fail to eliminate T cells in the medulla. Thus, exposure to 
ubiquitous self-antigen in the cortex could indeed impose a 
safety window, but we propose that this is not the case when 
T cells are negatively selected against TRA in the medulla. 
A less stringent selection against TRA than against ubiqui-
tously expressed self-antigen is consistent with the fact that 
T cell–mediated autoimmune responses often target TRA.
Although high avidity T cells are normally deleted in the 
thymus (Kisielow et al., 1988) or the periphery (Kurts et al., 
1997), it has also been shown that these T cells sometimes 
persist in the periphery (Schietinger et al., 2012). Interest-
ingly, these high avidity T cells show signs of prior activation 
and proliferation, they express high levels of CD44, and they 
are tolerant or anergic. In contrast, low avidity OT-3 T cells 
in Rip-mOva mice resembled naive T cells both phenotypi-
cally and functionally. They were CD44 low and showed no 
signs of previous antigen exposure. The observed tolerance 
of high but not low avidity T cells further supports the rele-
vance of low avidity T cells in autoimmune pathology.
Although the induction of islet damage and autoimmune 
diabetes required two consecutive infections to initiate auto-
immune diabetes in Rip-mOva mice, our data clearly dem-
onstrate that severe autoimmunity can occur in normal mice 
with an unmanipulated TCR repertoire and in the presence 
of regulatory T cells (Fig. 1). This also indicates that low 
avidity autoreactive T cells form memory cells and mount a 
robust secondary response upon antigen reexposure. This is 
another significant difference from high avidity autoreactive 
memory T cells which are removed from the T cell repertoire 
over time (Kreuwel et al., 2002). Moreover, the low num-
bers of autoreactive T cells seen after the primary infection 
implies that formation of memory T cells and repetitive stim-
ulation are likely required to generate sufficient numbers of 
autoreactive low avidity T cells to cause tissue damage. This 
is consistent with the proposed relapsing-remitting disease 
progression for type 1 diabetes (von Herrath et al., 2007), 
which proposes that multiple stimulations and increasing tis-
sue damage cause autoimmune diabetes.
In conclusion, we demonstrate that T cells specific for 
TRA escape negative selection and can cause autoimmunity 
because of a mismatch between the threshold for negative se-
lection to TRA and the threshold for T cell activation during 
an infection and the execution of effector function against 
peripheral tissues. This mismatch allows low avidity T cells to 
enter the periphery. Moreover, we showed that low avidity 
T cells, in contrast to high avidity T cells, persist without los-
ing their self-destructive potential. We consider that these 
dormant autoreactive T cells constitute a significant source 
for cells which, even in the absence of genetic predisposition 
to develop autoimmunity, are able to cause organ-specific 
autoimmune damage.
MATERIALS AND METHODS
Mice. Rip-mOva mice expressing a membrane-bound form of Ova under 
the control of Rip (Kurts et al., 1997), OT-I TCR transgenic mice recog-
nizing Kb/Ova257-264, CD45.1 congenic C57BL/6 mice, and H-2Kbm1 C57BL/6 
mice were all obtained from The Jackson Laboratory, and C57BL/6 mice 
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anti-CD8 PerCPCy5.5, anti-CD62L PE-Cy7, anti-CD44 PE, anti-CD5 PE, 
anti–PD-1 PE, anti-CD127 PE, anti-KLRG1 biotin, Streptavidin PE-Cy7 
(all from eBioscience), and anti-V5 (BD). Anti-CD4, anti-CD45.1, anti-
CD45.2, and the H-2Kb clone 5F1 were purified from hybridoma superna-
tants and coupled to Pacific blue, Alexa Fluor 647, or FITC using labeling 
reagents from Invitrogen. Cells were washed twice and fixed in PBS supple-
mented with 1% formaldehyde, 2% glucose, and 0.03% azide (Fix buffer). 
After 30 min, the Fix buffer was replaced with FACS buffer. For intracellular 
detection, cells were fixed and permeabilized using the Cytofix/Cytoperm 
kit (BD) and stained with anti–IFN- (obtained from Bio-XCell, coupled to 
Alexa Fluor 647 or FITC using labeling reagents from Invitrogen), anti–IFN- 
PE (eBioscience), TNF (eBioscience), or Granzyme B (Invitrogen). For 
sorting living cells, cells were stained in RPMI media containing 10% FCS 
and sorted on a FACSAria instrument (BD).
Data analyses. Flow cytometry measurements were performed on an LSR-II 
(BD) machine and the data were analyzed with FlowJo software (Tree Star). 
Graphs were prepared and EC50 concentrations were determined with Prism 
(GraphPad Software). The error bars or numbers show SD.
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